Understanding Practice Variations in the Management of Central Nervous System Germ Cell Tumours : Insights from the NUGA Survey
Year: 2026
Type: article
Study design: Observational Study
Abstract: OBJECTIVE: Central nervous system germ cell tumours (CNS GCTs) are more prevalent in Asia than in Western populations. Treatment approaches remain heterogeneous across different Asian countries. METHODS: Following a physical meeting of Asian specialists in Seoul in September 2024, an on-site and electronic survey was conducted among Asian specialists within the NeUro Germ cell Asia network to assess practice patterns and identify areas requiring consensus. RESULTS: Forty-two specialists from eight Asian countries participated. Findings highlight the need for an Asian consortium to standardize management. Key variations were noted in age stratification, necessity of biopsy, tumour marker cut-offs, classification of bifocal disease and management of basal ganglia tumours, the role of chemotherapy in germinomas, and radiotherapy dose and volume for non-germinomatous germ cell tumours (NGGCTs). CONCLUSION: This survey identifies substantial practice variation in CNS GCT management across Asia. Priority areas requiring consensus include biopsy indications, tumour marker interpretation, age-adapted treatment strategies, the role of radiotherapy alone in adolescent and young adult germinoma, and optimisation of chemotherapy and radiotherapy approaches for NGGCT.
Institutions: Chulalongkorn University, Chiang Mai University, Siriraj Hospital, Mahidol University, University Malaya Medical Centre, University of Malaya, Asan Medical Center, University of Ulsan, Prince of Wales Hospital, Philippine General Hospital, Philippine Children's Medical Center, KK Women's and Children's Hospital, Hyogo Ion Beam Medical Center, Taipei Medical University, National Cancer Center, Taipei Medical University Hospital
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $300
Funder: National Cancer Center
OpenAlex ID: W7223116882
